Stockreport

FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF – TNKase® (tenecteplase) is the first stroke medicine approved by the FDA in nearly 30 years –– Single five-second intravenous bolus provides faster and simpler administ [Read more]